MDLZ financial statements and SEC filings
MDLZ annual income statement
| Fiscal period end | Revenue | Operating income | Net income | SEC filing |
|---|
| 2025-12-31 | $38.54B | $3.55B | $2.45B | 10-K |
| 2024-12-31 | $36.44B | $6.34B | $4.61B | 10-K |
| 2023-12-31 | $36.02B | $5.50B | $4.96B | 10-K |
| 2022-12-31 | $31.50B | $3.53B | $2.72B | 10-K |
| 2021-12-31 | $28.72B | $4.65B | $4.30B | 10-K |
| 2020-12-31 | $26.58B | $3.85B | $3.56B | 10-K |
MDLZ annual balance sheet
| Fiscal period end | Assets | Liabilities | Equity | SEC filing |
|---|
| 2025-12-31 | $71.49B | $45.60B | $25.89B | 10-Q |
| 2024-12-31 | $68.50B | $41.54B | $26.96B | 10-K |
| 2023-12-31 | $71.39B | $43.02B | $28.37B | 10-K |
| 2022-12-31 | $71.16B | $44.24B | $26.92B | 10-K |
| 2021-12-31 | $67.09B | $38.77B | $28.32B | 10-K |
| 2020-12-31 | $67.81B | $40.16B | $27.65B | 10-K |
MDLZ annual cash flow
| Fiscal period end | Operating cash flow | Capital expenditure | Financing cash flow | SEC filing |
|---|
| 2025-12-31 | $4.51B | -$1.28B | -$2.76B | 10-K |
| 2024-12-31 | $4.91B | -$1.39B | -$5.78B | 10-K |
| 2023-12-31 | $4.71B | -$1.11B | -$7.56B | 10-K |
| 2022-12-31 | $3.91B | -$906.00M | -$456.00M | 10-K |
| 2021-12-31 | $4.14B | -$965.00M | -$4.07B | 10-K |
| 2020-12-31 | $3.96B | -$863.00M | -$2.21B | 10-K |